Annual accounts receivable:
$1.30B+$94.00M(+7.77%)Summary
- As of today (May 29, 2025), DGX annual accounts receivable is $1.30 billion, with the most recent change of +$94.00 million (+7.77%) on December 31, 2024.
- During the last 3 years, DGX annual accounts receivable has fallen by -$134.00 million (-9.32%).
- DGX annual accounts receivable is now -14.21% below its all-time high of $1.52 billion, reached on December 31, 2020.
Performance
DGX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$1.40B+$100.00M(+7.67%)Summary
- As of today (May 29, 2025), DGX quarterly accounts receivable is $1.40 billion, with the most recent change of +$100.00 million (+7.67%) on March 31, 2025.
- Over the past year, DGX quarterly accounts receivable has increased by +$82.00 million (+6.20%).
- DGX quarterly accounts receivable is now -7.63% below its all-time high of $1.52 billion, reached on December 31, 2020.
Performance
DGX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DGX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.8% | +6.2% |
| 3 y3 years | -9.3% | +2.4% |
| 5 y5 years | +22.7% | +44.4% |
DGX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.3% | +9.1% | at high | +17.5% |
| 5 y | 5-year | -14.2% | +22.7% | -7.6% | +44.4% |
| alltime | all time | -14.2% | +338.0% | -7.6% | +176.2% |
DGX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.40B(+7.7%) |
| Dec 2024 | $1.30B(+7.8%) | $1.30B(-5.2%) |
| Sep 2024 | - | $1.38B(+4.3%) |
| Jun 2024 | - | $1.32B(-0.2%) |
| Mar 2024 | - | $1.32B(+9.3%) |
| Dec 2023 | $1.21B(+1.3%) | $1.21B(-5.5%) |
| Sep 2023 | - | $1.28B(+3.7%) |
| Jun 2023 | - | $1.24B(-1.5%) |
| Mar 2023 | - | $1.25B(+4.9%) |
| Dec 2022 | $1.20B(-16.9%) | $1.20B(-6.6%) |
| Sep 2022 | - | $1.28B(-1.0%) |
| Jun 2022 | - | $1.29B(-5.7%) |
| Mar 2022 | - | $1.37B(-4.7%) |
| Dec 2021 | $1.44B(-5.4%) | $1.44B(-2.4%) |
| Sep 2021 | - | $1.47B(+17.4%) |
| Jun 2021 | - | $1.25B(-9.2%) |
| Mar 2021 | - | $1.38B(-9.1%) |
| Dec 2020 | $1.52B(+43.0%) | $1.52B(+7.0%) |
| Sep 2020 | - | $1.42B(+26.2%) |
| Jun 2020 | - | $1.13B(+15.8%) |
| Mar 2020 | - | $972.00M(-8.6%) |
| Dec 2019 | $1.06B(+5.0%) | $1.06B(-4.8%) |
| Sep 2019 | - | $1.12B(+2.7%) |
| Jun 2019 | - | $1.09B(+0.8%) |
| Mar 2019 | - | $1.08B(+6.6%) |
| Dec 2018 | $1.01B(+9.5%) | $1.01B(-7.7%) |
| Sep 2018 | - | $1.10B(+4.0%) |
| Jun 2018 | - | $1.05B(+2.8%) |
| Mar 2018 | - | $1.03B(+11.0%) |
| Dec 2017 | $924.00M(-0.2%) | $924.00M(-3.8%) |
| Sep 2017 | - | $960.00M(+1.4%) |
| Jun 2017 | - | $947.00M(-1.4%) |
| Mar 2017 | - | $960.00M(+3.7%) |
| Dec 2016 | $926.00M(+2.8%) | $926.00M(-4.1%) |
| Sep 2016 | - | $966.00M(-0.9%) |
| Jun 2016 | - | $975.00M(+2.4%) |
| Mar 2016 | - | $952.00M(+5.7%) |
| Dec 2015 | $901.00M(-3.3%) | $901.00M(-1.4%) |
| Sep 2015 | - | $914.00M(-2.5%) |
| Jun 2015 | - | $937.00M(-1.3%) |
| Mar 2015 | - | $949.00M(+1.8%) |
| Dec 2014 | $932.00M(+9.4%) | $932.00M(-2.2%) |
| Sep 2014 | - | $953.00M(-1.0%) |
| Jun 2014 | - | $963.00M(-1.4%) |
| Mar 2014 | - | $977.00M(+14.7%) |
| Dec 2013 | $852.00M | $852.00M(-7.5%) |
| Sep 2013 | - | $920.83M(-2.7%) |
| Jun 2013 | - | $946.75M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $929.97M(+7.3%) |
| Dec 2012 | $867.00M(-4.4%) | $867.00M(-6.8%) |
| Sep 2012 | - | $930.73M(-1.1%) |
| Jun 2012 | - | $941.47M(-3.3%) |
| Mar 2012 | - | $973.89M(+7.4%) |
| Dec 2011 | $906.46M(+7.2%) | $906.46M(-3.2%) |
| Sep 2011 | - | $936.26M(+0.7%) |
| Jun 2011 | - | $929.37M(-1.2%) |
| Mar 2011 | - | $940.36M(+11.2%) |
| Dec 2010 | $845.30M(+2.2%) | $845.30M(-2.8%) |
| Jun 2010 | - | $869.64M(+0.5%) |
| Mar 2010 | - | $865.16M(+4.6%) |
| Dec 2009 | $827.34M(-0.7%) | $827.34M(-6.9%) |
| Sep 2009 | - | $888.29M(-0.9%) |
| Jun 2009 | - | $896.53M(+0.9%) |
| Mar 2009 | - | $888.25M(+6.6%) |
| Dec 2008 | $832.87M(-5.6%) | $832.87M(-6.2%) |
| Sep 2008 | - | $888.12M(-3.7%) |
| Jun 2008 | - | $922.51M(-2.7%) |
| Mar 2008 | - | $947.74M(+7.5%) |
| Dec 2007 | $881.97M(+13.9%) | $881.97M(-8.4%) |
| Sep 2007 | - | $962.86M(-1.0%) |
| Jun 2007 | - | $973.07M(+20.0%) |
| Mar 2007 | - | $810.58M(+4.7%) |
| Dec 2006 | $774.41M(+5.7%) | $774.41M(-9.6%) |
| Sep 2006 | - | $857.03M(+7.1%) |
| Jun 2006 | - | $800.28M(+3.2%) |
| Mar 2006 | - | $775.72M(+5.8%) |
| Dec 2005 | $732.91M(+12.9%) | $732.91M(+5.6%) |
| Sep 2005 | - | $693.79M(+0.1%) |
| Jun 2005 | - | $693.38M(-1.3%) |
| Mar 2005 | - | $702.42M(+8.2%) |
| Dec 2004 | $649.28M(+6.6%) | $649.28M(-5.4%) |
| Sep 2004 | - | $686.04M(+1.2%) |
| Jun 2004 | - | $677.71M(+4.2%) |
| Mar 2004 | - | $650.51M(+6.8%) |
| Dec 2003 | $609.19M(+16.7%) | $609.19M(-5.4%) |
| Sep 2003 | - | $643.84M(+2.5%) |
| Jun 2003 | - | $628.40M(+2.4%) |
| Mar 2003 | - | $613.64M(+17.5%) |
| Dec 2002 | $522.13M(+2.7%) | $522.13M(-9.4%) |
| Sep 2002 | - | $576.46M(-3.5%) |
| Jun 2002 | - | $597.67M(+9.0%) |
| Mar 2002 | - | $548.40M(+7.9%) |
| Dec 2001 | $508.34M(+70.7%) | $508.34M(-1.0%) |
| Sep 2001 | - | $513.64M(-1.4%) |
| Jun 2001 | - | $520.87M(+2.3%) |
| Mar 2001 | - | $509.27M |
| Dec 1996 | $297.74M | - |
FAQ
- What is Quest Diagnostics Incorporated annual accounts receivable?
- What is the all time high annual accounts receivable for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated annual accounts receivable year-on-year change?
- What is Quest Diagnostics Incorporated quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly accounts receivable year-on-year change?
What is Quest Diagnostics Incorporated annual accounts receivable?
The current annual accounts receivable of DGX is $1.30B
What is the all time high annual accounts receivable for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual accounts receivable is $1.52B
What is Quest Diagnostics Incorporated annual accounts receivable year-on-year change?
Over the past year, DGX annual accounts receivable has changed by +$94.00M (+7.77%)
What is Quest Diagnostics Incorporated quarterly accounts receivable?
The current quarterly accounts receivable of DGX is $1.40B
What is the all time high quarterly accounts receivable for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly accounts receivable is $1.52B
What is Quest Diagnostics Incorporated quarterly accounts receivable year-on-year change?
Over the past year, DGX quarterly accounts receivable has changed by +$82.00M (+6.20%)